1. A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia. Issue 44 (22nd October 2021) Authors: Fadlyana, Eddy; Rusmil, Kusnandi; Tarigan, Rodman; Rahmadi, Andri Reza; Prodjosoewojo, Susantina; Sofiatin, Yulia; Khrisna, Citra V.; Sari, Rini Mulia; Setyaningsih, Lilis; Surachman, Fikrianti; Bachtiar, Novilia Sjafri; Sukandar, Hadyana; Megantara, Imam; Murad, Chrysanti; Pangesti, Krisna Nur A... Journal: Vaccine Issue: Volume 39:Issue 44(2021) Page Start: 6520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alternative Splicing of Disabled-1 Controls Multipolar-to-Bipolar Transition of Migrating Neurons in the Neocortex. (22nd August 2017) Authors: Zhang, Bin; Wang, Weiwei; Zhang, Zhenjie; Hu, Yaling; Meng, Fan; Wang, Fan; Lou, Huifang; Zhu, Liya; Godbout, Roseline; Duan, Shumin; Gao, Zhihua Journal: Cerebral cortex Issue: Volume 28:Number 10(2018) Page Start: 3457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correction to: MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Issue 8 (9th February 2021) Authors: Song, Mingxu; Yin, Yuan; Zhang, Jiwei; Zhang, Binbin; Bian, Zehua; Quan, Chao; Zhou, Leyuan; Hu, Yaling; Wang, Qifeng; Ni, Shujuan; Fei, Bojian; Wang, Weili; Du, Xiang; Hua, Dong; Huang, Zhaohui Journal: Protein & cell Issue: Volume 12:Issue 8(2021) Page Start: 668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exosome‐mediated delivery of miR‐204‐5p inhibits tumor growth and chemoresistance. (2nd July 2020) Authors: Yao, Surui; Yin, Yuan; Jin, Guoying; Li, Dan; Li, Min; Hu, Yaling; Feng, Yuyang; Liu, Yuhang; Bian, Zehua; Wang, Xue; Mao, Yong; Zhang, Jia; Wu, Zhimeng; Huang, Zhaohui Journal: Cancer medicine Issue: Volume 9:Number 16(2020) Page Start: 5989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Issue 11 (23rd August 2014) Authors: Song, Mingxu; Yin, Yuan; Zhang, Jiwei; Zhang, Binbin; Bian, Zehua; Quan, Chao; Zhou, Leyuan; Hu, Yaling; Wang, Qifeng; Ni, Shujuan; Fei, Bojian; Wang, Weili; Du, Xiang; Hua, Dong; Huang, Zhaohui Journal: Protein & cell Issue: Volume 5:Issue 11(2014) Page Start: 851 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MTOR-mediated metabolic reprogramming regulate microglia function in response to different stimuli. (September 2019) Authors: Hu, Yaling; Mai, Weihao; Chen, Lunhao; Cao, Kelei; Duan, Shumin; Gao, Zhihua Journal: IBRO reports Issue: Volume 6(2019)Supplement Page Start: S254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. MTOR‐mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysaccharide and ATP. Issue 5 (3rd December 2019) Authors: Hu, Yaling; Mai, Weihao; Chen, Lunhao; Cao, Kelei; Zhang, Bin; Zhang, Zhenjie; Liu, Yijun; Lou, Huifang; Duan, Shumin; Gao, Zhihua Journal: Glia Issue: Volume 68:Issue 5(2020) Page Start: 1031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients. (4th June 2020) Authors: Wang, Xiaoli; Guo, Xianghua; Xin, Qianqian; Pan, Yang; Hu, Yaling; Li, Jing; Chu, Yanhui; Feng, Yingmei; Wang, Quanyi Journal: Clinical infectious diseases Issue: Volume 71:Number 10(2020) Page Start: 2688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Issue 6 (June 2021) Authors: Wu, Zhiwei; Hu, Yaling; Xu, Miao; Chen, Zhen; Yang, Wanqi; Jiang, Zhiwei; Li, Minjie; Jin, Hui; Cui, Guoliang; Chen, Panpan; Wang, Lei; Zhao, Guoqing; Ding, Yuzhu; Zhao, Yuliang; Yin, Weidong Journal: Lancet infectious diseases Issue: Volume 21:Issue 6(2021) Page Start: 803 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Issue 2 (February 2021) Authors: Zhang, Yanjun; Zeng, Gang; Pan, Hongxing; Li, Changgui; Hu, Yaling; Chu, Kai; Han, Weixiao; Chen, Zhen; Tang, Rong; Yin, Weidong; Chen, Xin; Hu, Yuansheng; Liu, Xiaoyong; Jiang, Congbing; Li, Jingxin; Yang, Minnan; Song, Yan; Wang, Xiangxi; Gao, Qiang; Zhu, Fengcai Journal: Lancet infectious diseases Issue: Volume 21:Issue 2(2021) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗